Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).
Clinical trial NCT00288639 · COMPLETED
Trial details
- NCT number
- NCT00288639
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2007-12-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.